American Century Companies Inc Fate Therapeutics Inc Transaction History

American Century Companies Inc

  • $167 Billion
  • Q3 2024

A detailed history of American Century Companies Inc transactions in Fate Therapeutics Inc stock. As of the latest transaction made, American Century Companies Inc holds 185,409 shares of FATE stock, worth $424,586. This represents 0.0% of its overall portfolio holdings.

Number of Shares
185,409
Previous 166,255 11.52%
Holding current value
$424,586
Previous $545,000 18.9%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$3.12 - $5.57 $59,760 - $106,687
19,154 Added 11.52%
185,409 $648,000
Q2 2024

Aug 07, 2024
BUY
$3.26 - $7.08 $113,043 - $245,506
34,676 Added 26.35%
166,255 $545,000
Q1 2024

May 14, 2024
BUY
$3.54 - $8.35 $278,233 - $656,284
78,597 Added 148.35%
131,579 $965,000
Q4 2023

Feb 13, 2024
BUY
$1.65 - $3.94 $87,420 - $208,749
52,982 New
52,982 $198,000
Q3 2023

Nov 13, 2023
BUY
$2.02 - $5.04 $32,012 - $79,873
15,848 Added 74.71%
37,062 $78,000
Q2 2023

Aug 14, 2023
BUY
$4.76 - $6.59 $100,978 - $139,800
21,214 New
21,214 $100,000
Q4 2022

Feb 13, 2023
BUY
$9.86 - $23.83 $897,161 - $2.17 Million
90,990 Added 38.41%
327,880 $3.31 Million
Q3 2022

Nov 14, 2022
BUY
$21.04 - $36.06 $34,821 - $59,679
1,655 Added 0.7%
236,890 $5.31 Million
Q2 2022

Aug 12, 2022
BUY
$17.78 - $42.39 $329,996 - $786,758
18,560 Added 8.57%
235,235 $5.83 Million
Q1 2022

May 11, 2022
BUY
$29.67 - $60.28 $1.1 Million - $2.24 Million
37,090 Added 20.65%
216,675 $8.4 Million
Q4 2021

Feb 07, 2022
BUY
$47.84 - $64.34 $2.02 Million - $2.71 Million
42,141 Added 30.66%
179,585 $10.5 Million
Q3 2021

Nov 10, 2021
BUY
$59.27 - $95.73 $432,078 - $697,871
7,290 Added 5.6%
137,444 $8.15 Million
Q2 2021

Aug 05, 2021
BUY
$67.25 - $92.52 $22,327 - $30,716
332 Added 0.26%
130,154 $11.3 Million
Q1 2021

May 14, 2021
BUY
$72.16 - $117.4 $8.47 Million - $13.8 Million
117,395 Added 944.68%
129,822 $10.7 Million
Q4 2020

Feb 12, 2021
BUY
$38.09 - $100.95 $473,344 - $1.25 Million
12,427 New
12,427 $1.13 Million

Others Institutions Holding FATE

# of Institutions
175
Shares Held
115M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $222M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email